Richard Elliott Sterling MD FACS
Laryngology & Voice Disorders, Rhinology & Paranasal Sinus Disease, Sleep Medicine
Physician
Join to View Full Profile
1608 Walnut StFl 9Philadelphia, PA 19103
Phone+1 215-929-8301
Dr. Sterling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Richard Sterling, MD, is an Otolaryngologist (ENT) based in Philadelphia, PA. Dr. Sterling completed his education and training at Temple University Hospital and the Medical University of South Carolina. He has published several notable papers in the field of ENT and allergy. Dr. Sterling is a recognized Fellow of the American Academy of Otolaryngology - Head and Neck Surgery, the American Academy of Otolaryngic Allergy, and the American College of Surgeons.
Education & Training
Medical University of South CarolinaResidency, Otolaryngology - Head and Neck Surgery, 1989 - 1993
Temple University HospitalInternship, Otolaryngology - Head and Neck Surgery, 1988 - 1989
Lewis Katz School of Medicine at Temple UniversityClass of 1988
Certifications & Licensure
PA State Medical License 2013 - 2026
NJ State Medical License 2020 - 2025
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Fellow (AAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
- Fellow, American Academy of Otolaryngic Allergy FAAOA, 2001
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 25 citationsGrowth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis.Laurie A. Lee, Richard Sterling, Jorge Maspero, D. Clements, A. Ellsworth
The Journal of Allergy and Clinical Immunology. in Practice. 2014-07-01 - 23 citationsEfficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trialRichard Sterling, Jessica Lim, Lucy Frith, Neil G Snowise, Loretta Jacques
Respiratory Medicine. 2012-08-01
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
